Cited by 305Cannabis and Cannabinoid ResearchForensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

Open access

Morgan, Celia J. A., Schafer, Gráinne, Freeman, Tom P., Curran, H. Valerie·2010·British Journal of Psychiatry

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The two main constituents of cannabis, cannabidiol and Δ(9)-tetrahydrocannabinol (THC), have opposing effects both pharmacologically and behaviourally when administered in the laboratory. Street cannabis is known to contain varying levels of each cannabinoid. AIMS: To study how the varying levels of cannabidiol and THC have an impact on the acute effects of the drug in naturalistic settings. METHOD: Cannabis users (n = 134) were tested 7 days apart on measures of memory and psychotomimetic symptoms, once while they were drug free and once while acutely intoxicated by their own chosen smoked cannabis. Using an unprecedented methodology, a sample of cannabis (as well as saliva) was collected from each user and analysed for levels of cannabinoids. On the basis of highest and lowest cannabidiol content of cannabis, two groups of individuals were directly compared. RESULTS: Groups did not differ in the THC content of the cannabis they smoked. Unlike the marked impairment in prose recall of individuals who smoked cannabis low in cannabidiol, participants smoking cannabis high in cannabidiol showed no memory impairment. Cannabidiol content did not affect psychotomimetic symptoms, which were elevated in both groups when intoxicated. CONCLUSIONS: The antagonistic effects of cannabidiol at the CB(1) receptor are probably responsible for its profile in smoked cannabis, attenuating the memory-impairing effects of THC. In terms of harm reduction, users should be made aware of the higher risk of memory impairment associated with smoking low-cannabidiol strains of cannabis like 'skunk' and encouraged to use strains containing higher levels of cannabidiol.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1192/bjp.bp.110.077503

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria
Raine, A. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.555 · Cited by 2,164
The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin
Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users
Gossop, M., Darke, S. G., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995) · Addiction · doi:10.1046/j.1360-0443.1995.9056072.x · Cited by 1,341
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Rivermead Behavioural Memory Test
la Cour, P., & GALLAGHER, K. (1990) · Nordisk Psykologi · doi:10.1080/00291463.1990.10636996 · Cited by 992
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Wechsler Test of Adult Reading
(2001) · PsycTESTS Dataset · doi:10.1037/t15180-000 · Cited by 616

Show all 30 references

Research works printed but not linked: 5

10.1038/sj.npp.1300496 · DOI · Paper page
2006, Annual Report 2006: The State of the Drugs Problem in Europe
2009, Health Survey Findings for England 2008
Hardwick, 2008, Home Office Cannabis Potency Study
10.1016/j.biopsych.2006.08.027 · DOI

Sorted by citations

Items 201–300 of 305

Limitations to the Dutch cannabis toleration policy
van Laar, M., van der Pol, P., & Niesink, R. J. M. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.02.011 · Cited by 13
Cannabinoïdes de synthèse : une nouvelle matrice des addictions
Scocard, A., Benyamina, A., Coscas, S., & Karila, L. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2016.11.014 · Cited by 13
Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations
Macedo, A. C., de Faria, A. O. V., Bizzi, I. H., Moreira, F. A., Colasanti, A., & Ghezzi, P. (2022) · Journal of Cannabis Research · doi:10.1186/s42238-022-00145-w · Cited by 15
Guanfacine attenuates adverse effects of dronabinol (THC) on working memory in adolescent-onset heavy cannabis users: A pilot study
Mathai, D. S., Holst, M., Rodgman, C., Haile, C. N., Keller, J., Hussain, M. Z., Kosten, T. R., Newton, T. F., & Verrico, C. D. (2018) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.16120328 · Cited by 12
Manipulation Checking the Munchies: Validating Self-Reported Dietary Behaviors during Cannabis Intoxication
Kruger, J. S., Blavos, A. A., Castor, T. S., Wotring, A. J., Wagner-Greene, V. R., Glassman, T., & Kruger, D. J. (2019) · Human Ethology · doi:10.22330/he/34/010-016 · Cited by 12
Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure
D’Souza, D. C., Ganesh, S., Cortes-Briones, J., Campbell, M., & Emmanuel, M. K. (2019) · Psychological Medicine · doi:10.1017/s0033291719002721 · Cited by 13
Licensing and regulation of the cannabis market in England and Wales: Towards a cost-benefit analysisPreprint
Pudney, S. E., Bryan, M. L., & DelBono, E. (2013) · RePEc: Research Papers in Economics · Cited by 11
Understanding the Potential Benefits of Cannabidiol for Patients With Schizophrenia: A Narrative Review
Dyck, G. J. B., Maayah, Z. H., Eurich, D. T., & Dyck, J. R. B. (2021) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgab053 · Cited by 9
Current Status and Future of Cannabis Research
Russo, E. B., Mead, A., & Sulak, D. (2015) · doi:10.14524/cr-15-0004 · Cited by 8
The evaluation of Cannabidiol’s effect on the immunotherapy of Burkitt lymphoma
Togano, T., Kim, N., Kim, N., Park, G. S., Park, A. K., Bennet, M., & Park, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.001 · Cited by 8
Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder
Martin, E. L., & McRae‐Clark, A. L. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00342-8 · Cited by 8
Cannabis-Induced Psychotic Disorders
Pauselli, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00008-2 · Cited by 8
The Potential Use of Cannabidiol in the Treatment of Opioid Use Disorder: A Systematic Review
Shafie, M., Ing, K., Abadi, Y. R., Weleff, J., Griffin, M., Ranganathan, M., Aghaei, A. M., Pratt, N., Funaro, M. C., & Nia, A. B. (2025) · Addiction Biology · doi:10.1111/adb.70047 · Cited by 7
Assessing Cannabis Use Disorder in Medical Cannabis Patients: Interim Analyses from an Observational, Longitudinal Study
Sagar, K. A., Dahlgren, M. K., Smith, R. T., Lambros, A. M., & Gruber, S. A. (2021) · Cannabis · doi:10.26828/cannabis/2021.02.004 · Cited by 7
Cognitive test performance in chronic cannabis flower users, concentrate users, and non-users
Cuttler, C., Petrucci, A. S., & LaFrance, E. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-35217-1 · Cited by 7
Synthesis of (−)‐Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)‐Catalyzed Cycloisomerization
Carreras, J., Kirillova, M. S., & Echavarren, A. M. (2016) · Angewandte Chemie · doi:10.1002/ange.201601834 · Cited by 7
Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?
Naftali, T. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05763-8 · Cited by 7
Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys
Verrico, C. D., Mathai, D. S., Gu, H., Sampson, A. R., & Lewis, D. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119882857 · Cited by 8
Cannabidiol and the central nervous system: translating into clinics
Saviano, A., Raucci, F., Tallarico, M., Caro, C. D., Martino, S., Nesci, V., Roberti, R., Iannone, L. F., Colia, A. L., Dimonte, S., et al. (2021) · doi:10.36118/pharmadvances.2021.04 · Cited by 7
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’
Tănăsescu, R., Rog, D. J., & Constantinescu, C. S. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.560935 · Cited by 8
[Antibioresistance of Escherichia coli strains isolated from raw chicken meat in Senegal].
Fofana, A., Alambédji, R. B., Seydi, M., & Akakpo, A. J. (2006) · PubMed · Cited by 6
A comprehensive review of natural product-derived compounds acting on P2X7R: The promising therapeutic drugs in disorders
Liu, Z., Liu, W., Han, M., Wang, M., Li, Y., Yao, Y., & Duan, Y. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155334 · Cited by 6
Review of Marijuana Use in the Adolescent Population and Implications of its Legalization in the United States
Shekhar, A. (2014) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000165 · Cited by 6
Legalizing marijuana for medical purposes will increase risk of long-term, deleterious consequences for adolescents
Wright, M. J. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.005 · Cited by 6
The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review
Motaghi, E., Ghasemi-Pirbaluti, M., Rashidi, M., Alasvand, M., Ciano, P. D., & Bozorgi, H. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03454-y · Cited by 5
Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults
Raddo, M.-E. D., Milenkovic, M., Sivasubramanian, M., Hasbi, A., Bergman, J., Withey, S. L., Madras, B. K., & George, S. R. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100107 · Cited by 5
More harm than good? Cannabis, harm and the misuse of drugs act
Potter, G., & Wells, H. (2021) · Drugs and Alcohol Today · doi:10.1108/dat-09-2021-0047 · Cited by 4
Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development
Scott, J. C. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.03.012 · Cited by 5
Drug Resistance in Diabetes
Khaliq, A., Chughtai, M. F. J., Javed Iqbal, M., Nawaz, H., Ahsan, S., Mehmood, T., Liaqat, A., Nadeem, M., Sameed, N., Saeed, K., et al. (2021) · Springer eBooks · doi:10.1007/978-3-030-76320-6_16 · Cited by 4
Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?
Kitchigina, V. F. (2021) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-021-01148-5 · Cited by 7
Characteristics for Medical Cannabis Treatment Adherence among Autistic Children and Their Families: A Mixed-Methods Analysis
David, A., Stolar, O. E., Berkovitch, M., Kohn, E., Waisman-Nitzan, M., Hartmann, I., & Gal, E. (2024) · Medical Cannabis and Cannabinoids · doi:10.1159/000538901 · Cited by 7
Challenging CBD protective effect against THC‐related outcomes: a call for robust clinical trials
Mongeau‐Pérusse, V., & Jutras‐Aswad, D. (2020) · Addiction · doi:10.1111/add.15254 · Cited by 4
Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray
Schwittay, M. A., Steinbrecher, A., & Lobsien, E. (2021) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.613 · Cited by 4
Synthetic cannabinoids: new matrix addiction
Antsyborov, A. V., & Mrykhin, V. V. (2017) · Interactive science · doi:10.21661/r-118680 · Cited by 4
Looking ahead after 50 years of research on cannabinoids
Mechoulam, R. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch1 · Cited by 4
Perspectives toward cannabidiol ( CBD ) among youth in Early Psychosis Intervention programs: A qualitative study
Ghelani, A. (2023) · Early Intervention in Psychiatry · doi:10.1111/eip.13428 · Cited by 3
Oral cannabidiol did not impair learning and memory in healthy adults
Gebregzi, H. H., Zeiger, J. S., Smith, J. P., Stuyt, L., Cullen, L., Carsella, J., Rogers, D. C., Lafebre, J., Knalfec, J., Vargas, A. P.-D., et al. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00262-2 · Cited by 3
Cannabinoids for the treatment of cannabis abuse disorder
Rodríguez, A., & Zavala, C. (2018) · Medwave · doi:10.5867/medwave.2018.06.7286 · Cited by 3
Cannabis and Driving: Developing Guidelines for Safety Policies
Manetti, F., Chericoni, S., Marrocco, A. M., Scopetti, M., Padovano, M., Santurro, A., Frati, P., Gabbrielli, M., & Fineschi, V. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220616160459 · Cited by 3
The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms
Jalali, S. (2013) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2013/6192 · Cited by 3
Increasing Plant Concentrations of THC and Implications on Health Related Disorders
Vindenes, V., & Mørland, J. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00004-1 · Cited by 3
Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population
Solowij, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00005-7 · Cited by 3
Online information on medical cannabis may rise unrealistic expectations and downplay potential side effectsPreprint
Macedo, A. C., de Faria, A. O. V., Bizzi, I. H., Moreira, F. A., Colasanti, A., & Ghezzi, P. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2004.02330 · Cited by 3
Roles of Cannabidiol in Reversing ProteinopathiesPreprint
Dash, R., Ali, M. C., Jahan, I., Munni, Y. A., Mitra, S., Hannan, M. A., Timalsina, B., Oktaviani, D. F., Choi, H. J., & Moon, I. S. (2020) · Preprints.org · doi:10.20944/preprints202005.0340.v1 · Cited by 3
Should cannabis be used in the management of endometriosis?
Armour, M., Sinclair, J., Seaman, C., Mardon, A. K., Farooqi, T., Holtzman, O., & Leonardi, M. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2572339 · Cited by 2
Naturalistic investigation of cannabis strains varying in THC and CBD ratios and verbal recognition memory
Paulich, K. N., Place, C., Giordano, G., Carpenter, W. B., Curran, T., & Bidwell, L. C. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1685412 · Cited by 2
Mapping the acute effects of cannabis on multiple memory domains: A randomized, double-blind, placebo-controlled study
Cuttler, C., & McLaughlin, R. J. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261416079 · Cited by 2
Evidence from naturalistic studies can be strengthened by triangulation
Freeman, T. P., Scott, J., & Taylor, G. M. J. (2022) · Addiction · doi:10.1111/add.15891 · Cited by 2
Alterations of THC and CBD ratios and impact on cognition
Zamberletti, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00007-6 · Cited by 2
Rethinking dose-response effects of cannabis use in adolescence
Freeman, T. P., Mokrysz, C., & Curran, H. V. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00005-4 · Cited by 2
Cannabiskonsum zum Freizeitgebrauch
Schneider, M., Friemel, C. M., von Keller, R., Adorjan, K., Bonnet, U., Hasan, A., Hermann, D., Kambeitz, J., Koethe, D., Kraus, L., et al. (2018) · Springer eBooks · doi:10.1007/978-3-662-57291-7_3 · Cited by 2
Cannabidiol and Cannabis Use Disorder
García‐Gutiérrez, M. S., Navarrete, F., Viudez‐Martínez, A., Gasparyan, A., Caparrós, E., & Manzanares, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_5 · Cited by 2
Narrative Review of Cannabidiol as an Antipsychotic and Recommendations for Legal Regulations
Walkey, L. R. L., Tanguay, R. L., & el‐Guebaly, N. (2018) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000026 · Cited by 2
Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin Dependence
Wilson, J., Mills, K. L., Sunderland, M., Freeman, T. P., Teesson, M., Haber, P., & Marel, C. (2023) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-023-01071-5 · Cited by 2
Cognitive sequelae of cannabis use
Pacheco‐Colón, I., & González, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815298-0.00010-1 · Cited by 2
Estudio comparativo del funcionamiento neuropsicológico y neurofisiológico en consumidores habituales de cannabis y controles sanos
Bernal, L. Á. R., Piedrahita, J. C. M., Villa, A. M. Z., Grajales, J. D., & Pérez, G. A. C. (2024) · psicología desde el caribe · doi:10.14482/psdc.40.2.705.258 · Cited by 1
Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models
Bedillion, M. F., Moore, C. F., Weerts, E. M., Arout, C. A., Harris, H. M., & Haney, M. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_598 · Cited by 1
Cannabidiol: de nieuwe haarlemmerolie of een hype?
Niesink, R. J. M., & van Laar, M. (2012) · Verslaving · doi:10.1007/s12501-012-0020-5 · Cited by 1
The impact of cannabis use on intracarotid amobarbital testing
Domen, C. H., Shrestha, A., Chapman, K. E., & Drees, C. N. (2019) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2019.100328 · Cited by 1
Cannabis and Neuropsychiatric Effects
Rettew, D. C., Gundersen, D. C., Rapp, E. K., Riggs, P., Miller, C. L., Jackson, M., Sabet, K. A., Cort, B., & Bader, L. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_4 · Cited by 1
Sativex® for the treatment of Agitation & Aggression in Alzheimer’s Dementia in UK nursing homes (STAND): Protocol for a feasibility randomised controlled trial
Albertyn, C. P., Johar, I., Creese, B., Young, A. H., Carter, B., Velayudhan, L., Bhattacharyya, S., Silva, M. V. D., Samsi, K., Jafari, H., et al. (2023) · Health Open Research · doi:10.12688/healthopenres.13311.1 · Cited by 1
Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT
Bhattacharyya, S., Davies, C., Carter, B., McGuire, P. K., Brammer, M. J., Fusar‐Poli, P., Broome, M. R., Watson, S., Pérez, J., & Yung, A. R. (2024) · Efficacy and Mechanism Evaluation · doi:10.3310/ynfh9826 · Cited by 1
Endocannabinoids and Alzheimer's disease
Chen, C. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00026-8 · Cited by 1
Debut de un ataque de pánico en adolescente de 15 años inducido por consumo de cannabis: abordaje desde la atención primaria
López-Cortacans, G., García, R. P., & Artuñedo, A. P. (2015) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2014.06.003 · Cited by 1
Cannabidiol: An Overview of its Antipsychotic Properties
Peres, F. F., de Almeida, V., & Abílio, V. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00092-2 · Cited by 1
Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders
Deiana, S., & Zamberletti, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00014-8 · Cited by 1
Cross cultural studies on adolescent cannabis use and psychosis
Konings, M. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20111222mk
How marijuana makes you forget
Costandi, M. (2012) · Nature · doi:10.1038/nature.2012.10152
Key ingredient staves off marijuana memory loss
Frood, A. (2010) · Nature · doi:10.1038/news.2010.508
A General Survey of its Harmful Effects Submission to The Social Justice Policy Group
Brett, M. (2012)
EPIDEMIOLOGY Associations of Social Phobia and General Anxiety with Alcohol and Drug Use in A Community Sample of Adolescents
Fröjd, S. A., Ranta, K., Kaltiala‐Heino, R., & MARTTUNEN, M. J. (2010)
EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND THE CANNABINOID RECEPTOR AGONIST WIN55,212-2 ON BEHAVIOUR AND COGNITION IN RATS
Schulz, S. (2012) · State and University Library Bremen
A VET AOD Training Enhancement Project Cannabis Makes the Grade A resource to support the development of a 'cannabis competent' workforce in the AOD sector
White, M., ROCHE, A. M., Trifonoff, A., Matalon, E., & Elkins, K. (2014)
Uso do Canabidiol como protetor contra disfunções cognitivas associadas ao acúmulo de ferro cerebral em ratos Wistar
Fagherazzi, E. V. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Drug and non-drug reward processing in cigarette and cannabis users
Lawn, W. (2016) · UCL Discovery (University College London)
A Review of ∆-9-Tetrahydrocannabinol’s Effect on the Hippocampus and Evaluation of Behavioral Memory Impairment in Acute and Chronic Cannabis Users
Cozy, T. (2016) · Scholars' Bank (University of Oregon)
Evaluating The Effects of Cannabis Dependence and Abstinence on Cortical Inhibition and Working Memory in Schizophrenia
Goodman, M. S. (2015) · TSpace (University of Toronto)
Residual Effects of Cannabis on Young Drivers' Performance of Driving-Related Skills: An Interim Analysis
Pan, J. (2016) · TSpace (University of Toronto)
Acute and non-acute effects of cannabis in adolescents and adults
Mokrysz, C. (2017) · UCL Discovery (University College London)
Medisch gebruik van cannabis en zijn psychoactieve werking: een paradox?
Bawin, F. (2018) · Verslaving · doi:10.1007/s12501-018-0155-0
Cannabis and Medicinal Properties.
Madras, B. K. (2016) · PubMed
The Efficacy of Cannabidiol in Mitigating Delta-9-Tetrahydrocannabinol-induced Harms: A Systematic Review
de Freitas, & Alyson, L. (2020)
Acute and Repeated Effects of Synthetic Cannabinoid Agonism and Cannabinoid Receptor 1 Positive Allosteric Modulation
Trexler, K. R. (2019) · doi:10.33915/etd.4040
Neuroprotective Effects of Cannabidiol Following Concussion: A Case Study
Singh, J. (2019) · oURspace (University of Regina) · doi:10.82465/6521
Role of Cannabinoids in Pain Management
Russo, E. B., & Hohmann, A. G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1818-8_18
Neuroscience
Pearlson, G. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818174-4.00005-7
Cannabinoid Withdrawal Produces Altered Somatic and Emotionality-related Behavior in Mice
Trexler, K. R. (2017) · doi:10.33915/etd.6830
Cannabidiol: Overview, Complexities, and Opportunities for Behavioral Health
Weiss, S. R. B., & Howlett, K. D. (2022) · Psychiatry update · doi:10.1007/978-3-031-04874-6_3
Canabidiol em modelo pré-clínico de dor neuropática: uma avaliação dos aspectos sensoriais, emocionais e inflamatórios relacionados com a modulação da sensibilidade dolorosa
Cardoso, G. K. R. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2022.tde-01092022-134636
Cannabis use in relation to Pulse Pressure and Mean Arterial Pressure in US AdultsPreprint
Ruddy, S., Marzo, V. D., & Ngueta, G. (2023) · medRxiv · doi:10.1101/2023.05.12.23289921
Neurological Effects of Cannabis
Ross, I. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-35155-6_5
The Long-Term Effect of CBD Crystals and CBD Oil on Depressive-Associated Rat Behaviors
Yang, J., & Liu, S. (2020) · Journal of Emerging Investigators · doi:10.59720/20-150
Three cannabis products attenuated oxaliplatin-induced peripheral neuropathy by inhibiting proteins that mediate oxaliplatin transport.Preprint
Sun, K., Wu, Y., Yan, X., Tong, X., Liu, Y., Song, Y., Li, J., & Wu, D. (2023) · Research Square · doi:10.21203/rs.3.rs-3375771/v1
Cannabinoids
(2024) · doi:10.1093/med/9780192844088.003.0012
Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on Cannabis
da Costa-Oliveira, C., Pereira, M. L., de Carvalho, N. F., Silvério, L. A. L., Ramos, Y. J., & Mazzola, P. G. (2024) · Pharmacy · doi:10.3390/pharmacy12040100
A Self-Emulsifying Nanococktail of Pomegranate and Cannabidiol Reduces Cognitive Decline in Mice
Shoseyov, O., Palatnik, A., Dadon‐Freiberg, M., Dagan, O., & Shaltiel‐Karyo, R. (2025) · Nutrition and Dietary Supplements · doi:10.2147/nds.s484222
The effect of a synthetic cannabinoid agonist (nabilone) on unimodal tactile illusion correlates with a psychometric scores in healthy volunteers
Kassim, F. M., Davey, A. J. W., Tod, S., Rodger, J., Albrecht, M. A., & Martin-Iverson, M. T. (2025) · Scientific Reports · doi:10.1038/s41598-025-02280-9
Temporal Association Between Reported Use of Psychoactive Substances and Cognitive Function in Individuals With Multiple Sclerosis
Kim, J., Ehde, D. M., Alschuler, K. N., Fritz, N. E., & Kratz, A. L. (2025) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2025.08.005
Associations between medication use and multiple domains of cognitive function in people with multiple Sclerosis
Kim, J., Ginell, K. M., Marecle, S., Wernimont, C. W., Braley, T. J., Ehde, D. M., Alschuler, K. N., Fritz, N. E., & Kratz, A. L. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106854
Chronic cannabis use and the brain: a neurophysiological investigation into the effects on human memory and attention
Battisti, R. A. (2010) · Research Online (University of Wollongong)

Authors: Morgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V.
Affiliations: University College London (GB)
Corresponding author: Curran, H. Valerie
ORCID: Morgan, Celia J. A.
Freeman, Tom P.
Curran, H. Valerie
Venue: British Journal of Psychiatry
Publisher: Royal College of Psychiatrists
Published: 2010-10
Volume: 197
Issue: 4
Pages: 285-290
ISSN: 0007-1250 (ISSN-L)
1472-1465
DOI: 10.1192/bjp.bp.110.077503
OpenAlex: W2015441565
Cited by: 305
References: 30
Citations by year: 2026: 4 · 2025: 11 · 2024: 8 · 2023: 23 · 2022: 13 · 2021: 20 · 2020: 31 · 2019: 24 · 2018: 26 · 2017: 25 · 2016: 22 · 2015: 20 · 2014: 20 · 2013: 17 · 2012: 23
FWCI: 13.45
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.cambridge.org/core/terms (unspecified, 2650 d)
Locations: The British Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: Medical Research Council
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords: cannabidiol, delta-9-tetrahydrocannabinol, cannabis smoking, psychotomimetic effects, CB1 receptor antagonism, harm reduction, prose recall, cannabis users
MeSH terms: Adolescent, Alcohol Drinking, Analysis of Variance, Cannabidiol, Cannabinoids, Female, United Kingdom, Humans, Male, Marijuana Smoking, Memory, Memory Disorders, Psychiatric Status Rating Scales, Mental Recall, Saliva, Dronabinol, Verbal Learning, Receptor, Cannabinoid, CB1, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks